+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Small Animal Imaging (In-Vivo) - Global Strategic Business Report

  • PDF Icon

    Report

  • 189 Pages
  • May 2026
  • Region: Global
  • Market Glass, Inc.
  • ID: 5140277
The global market for Small Animal Imaging (In-Vivo) was estimated at US$1.4 Billion in 2025 and is projected to reach US$2.2 Billion by 2032, growing at a CAGR of 7.1% from 2025 to 2032. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Global Small Animal Imaging (In-Vivo) Market - Key Trends and Drivers Summarized

Why Is Small Animal Imaging Essential for Preclinical Studies?

Small animal imaging (in-vivo) is crucial for preclinical studies as it provides non-invasive, high-resolution imaging solutions for monitoring biological processes in live animals. This technology is extensively used in drug development, cancer research, cardiovascular studies, and neuroscience to assess disease progression, therapeutic efficacy, and pharmacokinetics. Small animal imaging techniques, such as Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET), Single Photon Emission Computed Tomography (SPECT), and Computed Tomography (CT), offer real-time, longitudinal, and quantitative data, enhancing the reliability and translational value of preclinical research. The increasing focus on personalized medicine, targeted therapies, and molecular imaging is driving the adoption of small animal imaging systems across research institutions, pharmaceutical companies, and academic laboratories.

How Are Technological Advancements Enhancing Small Animal Imaging?

Technological advancements are enhancing small animal imaging by integrating multi-modal, hybrid, and AI-driven imaging systems that provide comprehensive insights into biological processes. The development of multi-modal imaging systems combining MRI, PET, SPECT, and CT modalities is enabling researchers to capture multiple data points simultaneously, improving the accuracy and depth of preclinical studies. Innovations in AI-based image analysis, deep learning algorithms, and data management systems are facilitating automated, high-throughput, and quantitative analysis of imaging data, reducing the time and complexity of preclinical workflows. Furthermore, the emergence of portable, compact, and user-friendly imaging systems is expanding the accessibility of advanced imaging technologies to small and mid-sized research labs, enhancing collaboration and knowledge sharing.

Which Market Segments Are Leading the Adoption of Small Animal Imaging?

Imaging modalities include micro-MRI, PET, SPECT, CT, optical imaging (bioluminescence and fluorescence), and ultrasound, with optical imaging and PET leading the market due to their high sensitivity, specificity, and real-time imaging capabilities. Use case encompass oncology, neurology, cardiology, infectious diseases, and immunology, with oncology being the largest segment due to the high prevalence of cancer research and drug development studies. End-users include academic and research institutions, pharmaceutical and biotechnology companies, and contract research organizations (CROs), with academic and research institutions being the primary adopters due to their focus on basic research and translational studies. Geographically, North America and Europe are the largest markets for small animal imaging due to advanced research infrastructure, while Asia-Pacific is emerging as a high-growth region driven by increasing investments in life sciences, expanding R&D activities, and growing focus on precision medicine.

What Are the Key Drivers of Growth in the Small Animal Imaging Market?

The growth in the small animal imaging market is driven by several factors, including the rising demand for preclinical research and drug development, increasing adoption of multi-modal, hybrid, and AI-driven imaging systems, and advancements in non-invasive, high-resolution imaging technologies. The development of compact, portable, and user-friendly imaging systems is driving market adoption among academic and research institutions, pharmaceutical companies, and CROs. The growing demand for high-sensitivity, high-specificity, and real-time imaging modalities is expanding the market reach among diverse preclinical research applications. The increasing use of small animal imaging in oncology, neurology, cardiology, and immunology research, coupled with the demand for longitudinal, quantitative, and translational imaging solutions, is creating new opportunities for market growth. Additionally, the rising collaborations between research institutes, pharmaceutical companies, and imaging solution providers and the increasing investments in R&D for innovative imaging technologies are further supporting market expansion.

Report Scope

The report analyzes the Small Animal Imaging (In-Vivo) market, presented in terms of market value (US$). The analysis covers the key segments and geographic regions outlined below:
  • Segments: Modality (Optical Imaging Systems Modality, Micro-Magnetic Resonance Imaging Modality, Nuclear Imaging Modality, Other Modalities); Application (Monitoring Drug Treatment Response Application, Biodistribution Studies Application, Cancer Application, Cell Detection Application, Biomarkers Application, Other Applications)
  • Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Optical Imaging Systems Modality segment, which is expected to reach US$982.2 Million by 2032 with a CAGR of a 8.4%. The Micro-Magnetic Resonance Imaging Modality segment is also set to grow at 5.3% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, valued at $399.4 Million in 2025, and China, forecasted to grow at an impressive 6.8% CAGR to reach $385.2 Million by 2032. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Small Animal Imaging (In-Vivo) Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Small Animal Imaging (In-Vivo) Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Small Animal Imaging (In-Vivo) Market expected to evolve by 2032?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2032?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2025 to 2032.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of players such as Aspect Imaging Ltd., Berthold Technologies GmbH & Co. KG, Bruker Corp., LI-COR Biosciences, Inc., Mediso Ltd. and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the companies featured in this Small Animal Imaging (In-Vivo) market report include:

  • Aspect Imaging Ltd.
  • Berthold Technologies GmbH & Co. KG
  • Bruker Corp.
  • LI-COR Biosciences, Inc.
  • Mediso Ltd.
  • MILabs B.V.
  • Miltenyi Biotec GmbH
  • New England Biolabs, Inc.
  • Northridge Tri-Modality Imaging, Inc.
  • PerkinElmer, Inc.
  • Scanco Medical AG
  • Sofie Biosciences, Inc.
  • Thermo Fisher Scientific Inc.
  • Uvp. LLC

Domain Expert Insights

This market report incorporates insights from domain experts across enterprise, industry, academia, and government sectors. These insights are consolidated from multilingual multimedia sources, including text, voice, and image-based content, to provide comprehensive market intelligence and strategic perspectives. As part of this research study, the publisher tracks and analyzes insights from 43 domain experts. Clients may request access to the network of experts monitored for this report, along with the online expert insights tracker.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
  • How Trump’s Tariffs Impact the Market? The Big Question on Everyone’s Mind
  • Global Economic Update
  • Small Animal Imaging (In-Vivo) - Global Key Competitors Percentage Market Share in 2026 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2026 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Advancements in Non-Invasive, High-Resolution Imaging Technologies Propel Market Innovation
  • Increasing Focus on Personalized Medicine and Molecular Imaging Expands Addressable Market Opportunity
  • Integration of Multi-Modal Imaging Systems (MRI, PET, SPECT, CT) Reinforces Market Competitiveness
  • Rising Investments in Oncology, Neurology, and Cardiovascular Research Spurs Market Adoption
  • Focus on Enhancing Imaging Sensitivity, Specificity, and Quantitative Analysis Drives Market Demand
  • Emergence of AI-Driven Image Analysis and Deep Learning Algorithms in Small Animal Imaging Accelerates Market Transformation
  • Growing Use of Fluorescence, Bioluminescence, and Ultrasound Imaging in In-Vivo Studies Sustains Market Growth
  • Development of Compact, User-Friendly, and High-Throughput Imaging Systems Expands Market Reach
  • Rising Preference for Longitudinal, Real-Time, and 4D Imaging Modalities Generates New Growth Opportunities
  • Growing Application of Small Animal Imaging in Infectious Diseases, Immunology, and Regenerative Medicine Spurs Market Expansion
  • Shift Towards Hybrid Imaging Platforms, Portable Solutions, and Remote Data Analysis Supports Market Growth
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Small Animal Imaging (In-Vivo) Market Analysis of Annual Sales in US$ Thousand for Years 2020 through 2032
  • Table 2: World Recent Past, Current & Future Analysis for Small Animal Imaging (In-Vivo) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 3: World Historic Review for Small Animal Imaging (In-Vivo) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 4: World 13-Year Perspective for Small Animal Imaging (In-Vivo) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2020, 2026 & 2032
  • Table 5: World Recent Past, Current & Future Analysis for Optical Imaging Systems Modality by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 6: World Historic Review for Optical Imaging Systems Modality by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 7: World 13-Year Perspective for Optical Imaging Systems Modality by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
  • Table 8: World Recent Past, Current & Future Analysis for Micro-Magnetic Resonance Imaging Modality by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 9: World Historic Review for Micro-Magnetic Resonance Imaging Modality by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 10: World 13-Year Perspective for Micro-Magnetic Resonance Imaging Modality by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
  • Table 11: World Recent Past, Current & Future Analysis for Nuclear Imaging Modality by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 12: World Historic Review for Nuclear Imaging Modality by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 13: World 13-Year Perspective for Nuclear Imaging Modality by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
  • Table 14: World Recent Past, Current & Future Analysis for Other Modalities by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 15: World Historic Review for Other Modalities by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 16: World 13-Year Perspective for Other Modalities by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
  • Table 17: World Recent Past, Current & Future Analysis for Monitoring Drug Treatment Response Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 18: World Historic Review for Monitoring Drug Treatment Response Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 19: World 13-Year Perspective for Monitoring Drug Treatment Response Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
  • Table 20: World Recent Past, Current & Future Analysis for Biodistribution Studies Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 21: World Historic Review for Biodistribution Studies Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 22: World 13-Year Perspective for Biodistribution Studies Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
  • Table 23: World Recent Past, Current & Future Analysis for Cancer Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 24: World Historic Review for Cancer Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 25: World 13-Year Perspective for Cancer Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
  • Table 26: World Recent Past, Current & Future Analysis for Cell Detection Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 27: World Historic Review for Cell Detection Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 28: World 13-Year Perspective for Cell Detection Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
  • Table 29: World Recent Past, Current & Future Analysis for Biomarkers Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 30: World Historic Review for Biomarkers Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 31: World 13-Year Perspective for Biomarkers Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
  • Table 32: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 33: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 34: World 13-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
III. MARKET ANALYSIS
UNITED STATES
  • Small Animal Imaging (In-Vivo) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2026 (E)
CANADA
JAPAN
  • Small Animal Imaging (In-Vivo) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2026 (E)
CHINA
  • Small Animal Imaging (In-Vivo) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2026 (E)
EUROPE
  • Small Animal Imaging (In-Vivo) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2026 (E)
FRANCE
  • Small Animal Imaging (In-Vivo) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2026 (E)
GERMANY
  • Small Animal Imaging (In-Vivo) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2026 (E)
ITALY
UNITED KINGDOM
  • Small Animal Imaging (In-Vivo) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2026 (E)
REST OF EUROPE
ASIA-PACIFIC
  • Small Animal Imaging (In-Vivo) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2026 (E)
REST OF WORLD
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Aspect Imaging Ltd.
  • Berthold Technologies GmbH & Co. KG
  • Bruker Corp.
  • LI-COR Biosciences, Inc.
  • Mediso Ltd.
  • MILabs B.V.
  • Miltenyi Biotec GmbH
  • New England Biolabs, Inc.
  • Northridge Tri-Modality Imaging, Inc.
  • PerkinElmer, Inc.
  • Scanco Medical AG
  • Sofie Biosciences, Inc.
  • Thermo Fisher Scientific Inc.
  • Uvp. LLC

Table Information